Keyword Analysis & Research: kite pharmaceuticals
Keyword Research: People who searched kite pharmaceuticals also searched
Search Results related to kite pharmaceuticals on Search Engine
-
Kite Pharma, Changing the Way Cancer is Treated
https://www.kitepharma.com/
Web ResultKite is dedicated to curing cancer. Learn about the science of cell therapy, our cancer research, and our cancer treatments in the pipeline.
DA: 1 PA: 63 MOZ Rank: 6
-
Careers at Kite Pharma
https://www.kitepharma.com/careers/careers-at-kite
Web ResultIf you want to change the future of cancer, learn about open career opportunities at Kite.
DA: 35 PA: 34 MOZ Rank: 47
-
Transformational Cancer Treatment | Kite Pharma
https://www.kitepharma.com/about-us/our-mission
Web ResultTransformational Cancer Treatment. At Kite, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. We believe cell therapy has the ability to change the way cancer is treated. Our industry-leading cell therapy …
DA: 1 PA: 95 MOZ Rank: 69
-
U.S. FDA Approves Kite’s Tecartus® as the First and Only Car T …
https://www.gilead.com/news-and-press/press-room/press-releases/2021/10/us-fda-approves-kites-tecartus-as-the-first-and-only-car-t-for-adults-with-relapsed-or-refractory-bcell-acute-lymphoblastic-leukemia
Web ResultOct 1, 2021 · SANTA MONICA, Calif.-- (BUSINESS WIRE)-- Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has granted approval for Tecartus ® (brexucabtagene autoleucel) for the treatment of adult patients (18 years and older) with relapsed or refractory B-cell precursor …
DA: 77 PA: 47 MOZ Rank: 69
-
Kite Pharma | LinkedIn
https://www.linkedin.com/company/kite-pharma-inc-
Web ResultKite Pharma | 139,416 followers on LinkedIn. At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer.
DA: 70 PA: 72 MOZ Rank: 71
-
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D …
https://www.gilead.com/news-and-press/press-room/press-releases/2021/7/biontech-to-acquire-kites-neoantigen-tcr-cell-therapy-rd-platform-and-manufacturing-facility-in-gaithersburg-md
Web ResultJul 19, 2021 · About Kite Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, with commercial manufacturing operations in North America and Europe. Kite’s singular focus is cell therapy to treat and potentially cure cancer.
DA: 33 PA: 25 MOZ Rank: 23
-
U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T …
https://www.gilead.com/news-and-press/press-room/press-releases/2020/7/us-fda-approves-kites-tecartus-the-first-and-only-car-t-treatment-for-relapsed-or-refractory-mantle-cell-lymphoma
Web ResultJul 24, 2020 · SANTA MONICA, Calif.-- (BUSINESS WIRE)-- Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel, formerly KTE-X19), the first and only approved …
DA: 82 PA: 98 MOZ Rank: 47
-
Kite Pharma - Wikipedia
https://en.wikipedia.org/wiki/Kite_Pharma
Web ResultKite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on …
DA: 81 PA: 59 MOZ Rank: 27
-
Gilead to buy Kite for promising cancer therapies in $12 billion deal
https://www.reuters.com/article/idUSKCN1B810S/
Web ResultAug 28, 2017 · (Reuters) - Gilead Sciences Inc agreed to buy Kite Pharma Inc in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with an emerging and expensive...
DA: 64 PA: 84 MOZ Rank: 82
-
Our Focus on Cell Therapy | Kite Pharma
https://www.kitepharma.com/about-us/our-story
Web ResultFounded in 2009 and acquired by Gilead Sciences in 2017, Kite has been a pioneer in cell therapy research and leader in the immuno-oncology space.
DA: 19 PA: 39 MOZ Rank: 44